GNH USA

Europe — EMA

Labetalol Pharmakern

GNH USA supplies Labetalol Pharmakern (Labetalol), an alpha/beta‑adrenergic blocker for hypertensive emergencies and severe hypertension.

Labetalol Hydrochloride

Request sourcing

1
Pack/s

What is Labetalol Hydrochloride?

Labetalol, the active ingredient in Labetalol Pharmakern, is an alpha/beta‑adrenergic blocker presented as an injectable solution for intravenous use. It treats hypertensive emergencies and severe hypertension in adult patients. GNH USA supplies Labetalol Pharmakern as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Labetalol Hydrochloride used for?

Labetalol is indicated for conditions involving acute or severe elevation of arterial pressure. - Hypertensive emergencies: rapid reduction of dangerously high blood pressure. - Severe hypertension: sustained lowering of markedly elevated arterial pressure. - Pre‑eclampsia: control of blood pressure in pregnant patients with this complication.

What are the side effects of Labetalol Hydrochloride?

Labetalol may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dizziness or light‑headedness. - Headache. - Nausea or vomiting. - Fatigue.

Serious or Rare Side Effects: - Severe hypotension. - Bronchospasm, especially in patients with asthma. - Hepatic dysfunction or elevated liver enzymes.

What precautions apply to Labetalol Hydrochloride?

Before initiating therapy, clinicians should evaluate several safety factors. - Blood pressure monitoring: ensure gradual reduction to avoid ischemia. - Cardiac function assessment: caution in patients with heart failure or conduction disorders. - Respiratory history: avoid in uncontrolled asthma or severe COPD. - Hepatic impairment: consider dose adjustment or alternative therapy. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

What does Labetalol Hydrochloride interact with?

Labetalol can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs). - Other potent antihypertensives (e.g., ACE inhibitors, diuretics). - Additional beta‑blockers.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs) may blunt blood‑pressure response. - Antidiabetic agents: labetalol may mask hypoglycaemia symptoms. - Certain anaesthetic agents: may enhance hypotensive effects.

Frequently asked questions

What is Labetalol Pharmakern used for?+
Labetalol Pharmakern is an intravenous formulation of labetalol used primarily to manage hypertensive emergencies and severe hypertension. By rapidly lowering elevated arterial pressure, it helps prevent end‑organ damage in acute settings such as malignant hypertension, aortic dissection, or cerebrovascular crises.
How does labetalol work to lower blood pressure?+
Labetalol blocks both β‑adrenergic (β1 and β2) and α1‑adrenergic receptors. β‑blockade reduces heart rate and contractility, decreasing cardiac output, while α1‑blockade causes vasodilation by relaxing peripheral vessels. The combined effect lowers systemic vascular resistance and overall blood pressure.
What determines the dose of Labetalol Pharmakern?+
The dose of Labetalol Pharmakern is individualized by the prescribing clinician based on the severity of hypertension, patient weight, renal and hepatic function, and response to therapy. Dosing regimens are adjusted in a controlled setting to achieve target blood‑pressure goals while avoiding rapid over‑correction.
Is labetalol safe during pregnancy or breastfeeding?+
Safety data for intravenous labetalol in pregnancy are limited, and the product lacks a definitive pregnancy‑category assignment. Clinicians weigh potential benefits against risks, and labetalol is generally reserved for severe cases where alternative therapies are unsuitable. Breastfeeding considerations should follow local guidelines and professional judgment.
How do I order Labetalol Pharmakern from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does labetalol compare with other antihypertensive agents?+
Labetalol’s dual α‑ and β‑blocking profile distinguishes it from agents that target only one receptor class. Compared with pure β‑blockers, it offers additional vasodilation, reducing the risk of reflex tachycardia. Relative to calcium‑channel blockers, it provides more direct heart‑rate control, making it useful in acute, high‑risk hypertension.
What are the recommended storage conditions for Labetalol Pharmakern?+
Labetalol Pharmakern should be stored at room temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct sunlight, and avoid freezing. Follow any specific manufacturer instructions on the label for optimal stability.
How is Labetalol Pharmakern administered to patients?+
The product is administered intravenously by a healthcare professional. It is typically given as a slow infusion or intermittent bolus, with continuous blood‑pressure monitoring. The infusion rate is adjusted according to the patient’s hemodynamic response and target blood‑pressure parameters.
What are the most serious risks to watch for with labetalol?+
Serious adverse events include profound hypotension, bronchospasm in patients with reactive airway disease, hepatic injury, and cardiac conduction disturbances such as heart block. Prompt recognition of these signs and immediate medical intervention are essential to prevent complications.
Who should not receive Labetalol Pharmakern?+
Labetalol is contraindicated in patients with known hypersensitivity to labetalol or any component of the formulation, severe bradycardia, advanced heart block without a pacemaker, and uncontrolled asthma or severe chronic obstructive pulmonary disease. Caution is also advised in patients with hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Labetalol Hydrochloride
Route
Intravenous Use
Manufacturer
Pharmakern Portugal – Produtos Farmacêuticos, Sociedade Unipessoal, Lda.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU